William Ashton's Net Worth
$1.91 Million
Who is William Ashton?
William Ashton has an estimated net worth of $1.91 Million. This is based on reported shares across multiple companies, which include Sucampo Pharmaceuticals, Inc., GALENA BIOPHARMA, INC., Societal CDMO, Inc., Baudax Bio, Inc., and SPECTRUM PHARMACEUTICALS INC.
SEC CIK
William Ashton's CIK is 0001474553
Past Insider Trading and Trends
2015 was William Ashton's most active year for acquiring shares with 10 total transactions. William Ashton's most active month to acquire stocks was the month of April. 2015 was William Ashton's most active year for disposing of shares, totalling 16 transactions. William Ashton's most active month to dispose stocks was the month of February. 2015 saw William Ashton paying a total of $762,699.80 for 239,766 shares, this is the most they've acquired in one year. In 2015 William Ashton cashed out on 259,532 shares for a total of $2,260,372.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sucampo Pharmaceuticals, Inc. No price found
InvestorWilliam Ashton used to own units in Class A Common Stock but no longer holds any shares there.acquired a total of 129,766 shares in Sucampo Pharmaceuticals, Inc. at a cost of $762,699.80, William also disposed a total of 129,766 shares of Sucampo Pharmaceuticals, Inc. equalling to $2,260,372.38.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$11.65 | -$1,497,672.58 |
0
|
Mar 11 - Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GALENA BIOPHARMA, INC. (SLS) Snapshot price: $1.16
InvestorWilliam Ashton owns 38,154 units of Common Stock which is worth $44,258.64. In the year 2013 William Ashton filed a total of 9 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +68.21% | 15.47K |
$0.38 | $5,879.36 | 38.15K |
Oct 10
| |||
Form 4
| +76.98% | 9.87K |
$0.59 | $5,820.94 | 22.68K |
Jun 8 - Jul 6
| |||
Form 4
| +335.03% | 9.87K |
$0.59 | $5,823.30 | 12.82K |
Apr 10
| |||
Form 4
|
∞
| 2.95K |
$1.98 | $5,833.08 | 2.95K |
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Societal CDMO, Inc. (SCTL) No price found
InvestorWilliam Ashton used to own units in Common Stock but no longer holds any shares there. From 2014 to 2024 William Ashton acquired a total of 263,622 shares in Societal CDMO, Inc. at a cost of $10,111.01, William also disposed a total of 263,622 shares of Societal CDMO, Inc. equalling to $289,984.20.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -263.62K |
$1.10 | -$289,984.20 |
0
|
Apr 8
| |||
Form 4
| +9.21% | 22.22K |
$0.46 | $10,111.01 | 263.62K |
Aug 28
| |||
Form 4
| +43.88% | 73.62K |
—
|
—
| 241.4K |
May 17
| |||
Form 4
| +108.99% | 87.5K |
—
|
—
| 167.78K |
May 18
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 4
| +50.46% | 26.92K |
—
|
—
| 80.28K |
Apr 20
| |||
Form 4
| +18.59% | 8.36K |
—
|
—
| 53.36K |
May 7
| |||
Form 4
| +64.14% | 17.58K |
—
|
—
| 44.99K |
Dec 5
| |||
Form 4
| +40.89% | 7.96K |
—
|
—
| 27.41K |
May 9
| |||
Form 4
| +214.69% | 13.27K |
—
|
—
| 19.46K |
May 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
∞
| 6.18K |
—
|
—
| 6.18K |
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Baudax Bio, Inc. (BXRX) Snapshot price: $0.0218
InvestorWilliam Ashton owns 42,534 units of Common Stock which is worth $927.24. In the year 2019 William Ashton filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,289.55% | 39.47K |
—
|
—
| 42.53K |
Jun 15
| |||
Form 4
| +111.27% | 56.45K |
—
|
—
| 107.19K |
Apr 7
| |||
Form 4
| +82.61% | 22.95K |
—
|
—
| 50.73K |
May 6
| |||
Form 4
| +257.00% | 20K |
—
|
—
| 27.78K |
Dec 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SPECTRUM PHARMACEUTICALS INC No price found
InvestorWilliam Ashton used to own units in Common Stock, $0.001 par value but no longer holds any shares there. In the year 2018 William Ashton filed a total of 10 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -67.66K |
—
|
—
|
0
|
Jul 31
| |||
Form 4
| +58.60% | 25K |
—
|
—
| 67.66K |
Aug 31
| |||
Form 4
| -9.12% | -4.28K |
$0.79 | -$3,362.15 | 42.66K |
Scheduled
|
Jun 21
| ||
Form 4
| +12.67% | 5.28K |
$4.24 | -$38,160.00 | 46.94K |
Scheduled
|
Jun 17 - Jun 18
| ||
Form 4
| -10.71% | -5.00K |
$3.25 | -$16,250.00 | 41.67K |
Scheduled
|
Jun 18 - Jun 22
| ||
Form 4
| +180.01% | 30K |
—
|
—
| 46.67K |
Jun 18
| |||
Form 4
| +25.00% | 3.33K |
$8.57 | -$57,119.50 | 16.67K |
Scheduled
|
Jun 19 - Jun 20
| ||
Form 4
| +33.33% | 3.33K |
—
|
—
| 13.33K |
Nov 30
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |